Readout LOUD podcast: NIH grant cuts, biotech M&A
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and ...
Our Season 2 – Innovations in Oncology – continues with a focus on precision medicine. I talk with CEO of ...
We are raiding the Guardian Long Read archives to bring you some classic pieces from years past, with new introductions ...
“I think he actually got it while he was climbing on a climbing trip. And it was bad, but it ...
Health data is a prime target of hackers given the value of healthcare data – in fact it is considered ...
This is the 22nd and final episode of the MedCity Moves podcast. Moving forward, Senior Reporter Katie Adams will continue ...
MAN v FAT is fortunate to have some incredible content creators within our community, spreading the word on the programme ...
We are in the final season of Pivot for the year and the topic for the last quarter is Employer-Led ...
Madeleine Finlay is joined by Ian Sample, the Guardian’s science editor and Science Weekly co-host, to answer the questions we ...
Dr. Timothy Showalter is a radiation oncologist and chief medical officer at AI company Artera. In the last episode of ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.